Discontinued — last reported Q4 '25
Medtronic Interest Paid decreased by 93.3% to $31.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 42.6%, from $54.00M to $31.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 7.0% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q1 '21 | Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $248.00M | $63.00M | $217.00M | $15.00M | $245.00M | $68.00M | $166.00M | $28.00M | $344.00M | $84.00M | $392.00M | $92.00M | $258.00M | $119.00M | $394.00M | $54.00M | $195.00M | $81.00M | $461.00M | $31.00M |
| QoQ Change | — | -74.6% | +244.4% | -93.1% | >999% | -72.2% | +144.1% | -83.1% | >999% | -75.6% | +366.7% | -76.5% | +180.4% | -53.9% | +231.1% | -86.3% | +261.1% | -58.5% | +469.1% | -93.3% |
| YoY Change | — | — | — | — | -1.2% | +7.9% | -23.5% | +86.7% | +40.4% | +23.5% | +136.1% | +228.6% | -25.0% | +41.7% | +0.5% | -41.3% | -24.4% | -31.9% | +17.0% | -42.6% |